Project Team Leader (PTL) at Abata Therapeutics

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Oncology, PharmaceuticalsIndustries

Requirements

PhD, PharmD, or other advanced degree preferred
Greater than 10 years of extensive clinical trial, drug development, and regulatory experience, with a strong scientific background
Demonstrated ability to lead through influence, managing project teams in a matrix environment rather than direct line management
Significant late-stage clinical development experience and exposure to different therapeutic modalities
Oncology and autoimmune experience highly desirable
Willingness to travel domestically and internationally as required

Responsibilities

Architect and execute comprehensive lifecycle strategies that maximize the value of the asset for patients, physicians, payors, and Janux
Ensure alignment with corporate objectives and deliver sustained impact across the portfolio
Create and communicate a compelling vision for designing, conducting, and executing innovative clinical development plans through registration
Develop and contribute to overall strategy for specific diseases/indications, ensuring a franchise-wide portfolio perspective
Provide strategic insights and recommendations to optimize clinical development plans
Anticipate and proactively address challenges across the development continuum, including risk assessment, mitigation planning, and adaptation to evolving regulatory and competitive landscapes
Collaborate closely with Clinical Development, Regulatory Strategy, and Clinical Operations to deliver high-quality drug approval applications, ensuring successful regulatory outcomes and market access
Collaborate with cross-functional teams to continuously refine clinical strategies, leveraging translational science, real-world evidence, and stakeholder feedback to optimize program outcomes
Lead and develop a cross-functional asset team comprised of Clinical Development, Clinical Sciences, Clinical Operations, Clinical Pharmacology, Program Management, Translational Oncology, CMC, Regulatory, and other functions as needed
Foster an effective, ethical, and inclusive culture that encourages teamwork, peer review, cooperation, and continuous improvement
Champion diversity of thought, accountability, integrity, and process excellence
Collaborate closely with leaders in Research, Development, Regulatory, and other key functional areas
Build and maintain relationships with external leaders, physicians, and patient advocacy groups
Be recognized internally and externally as an expert in the field, representing the organization at speaking engagements and industry forums
Perform other duties as assigned

Skills

Oncology Drug Development

Clinical Development

Regulatory Strategy

Clinical Operations

Project Management

Cross-Functional Leadership

Lifecycle Management

Risk Assessment

Strategic Planning

Portfolio Management

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free